Variant report
Variant | nsv879552 |
---|---|
Chromosome Location | chr4:91691313-91729462 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-MMRN1-6 | chr4:91701593-91701922 | NONHSAT097411 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7693519 | chr4:91691313-91691314 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540615288 | chr4:91691351-91691352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs192395093 | chr4:91691482-91691483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79742460 | chr4:91691485-91691486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs542933911 | chr4:91691582-91691583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562706823 | chr4:91691592-91691593 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs531796229 | chr4:91691593-91691594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372157441 | chr4:91691596-91691597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550213056 | chr4:91691597-91691598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564205217 | chr4:91691619-91691620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184291501 | chr4:91691639-91691640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188698813 | chr4:91691647-91691648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs546555097 | chr4:91691663-91691664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs16996235 | chr4:91691671-91691672 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs535714602 | chr4:91691692-91691693 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs368985052 | chr4:91691750-91691751 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs549309610 | chr4:91691784-91691785 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548111615 | chr4:91691797-91691798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs139681594 | chr4:91691798-91691799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs55897727 | chr4:91691832-91691833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528957311 | chr4:91691860-91691861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569590188 | chr4:91691863-91691864 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199937569 | chr4:91691940-91691941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538038896 | chr4:91691956-91691957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149864604 | chr4:91691985-91691986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181277884 | chr4:91692022-91692023 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534058033 | chr4:91692032-91692033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs554106839 | chr4:91692034-91692035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186259773 | chr4:91692135-91692136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542872354 | chr4:91692188-91692189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146875408 | chr4:91692216-91692217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs976483 | chr4:91692287-91692288 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs189016444 | chr4:91692289-91692290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs112471040 | chr4:91692296-91692297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs187306112 | chr4:91692418-91692419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs371833576 | chr4:91692475-91692476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539970409 | chr4:91692481-91692482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192150950 | chr4:91692582-91692583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs62313022 | chr4:91692595-91692596 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs551630200 | chr4:91692616-91692617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140669423 | chr4:91692710-91692711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs80160889 | chr4:91692715-91692716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34848155 | chr4:91692716-91692717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536837493 | chr4:91692717-91692718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531673583 | chr4:91692729-91692730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397763864 | chr4:91692733-91692734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372188933 | chr4:91692734-91692735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs77918553 | chr4:91692738-91692739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373422022 | chr4:91692761-91692762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs377034382 | chr4:91692786-91692787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Parkinson disease | 20877625 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Obesity | 20622171 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Cancer | 21272361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:91691200-91691400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
2 | chr4:91691200-91692200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr4:91692200-91696600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr4:91696600-91697200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr4:91697000-91697200 | Active TSS | Pancreas | Pancrea |
6 | chr4:91697200-91703600 | Weak transcription | Pancreas | Pancrea |
7 | chr4:91697600-91698200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr4:91698200-91699200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
9 | chr4:91699200-91699800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr4:91699800-91700800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr4:91700400-91713000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr4:91700800-91701600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr4:91710200-91710600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr4:91713000-91714200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
15 | chr4:91713600-91714200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr4:91713800-91714000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
17 | chr4:91713800-91714000 | Enhancers | Gastric | stomach |
18 | chr4:91720200-91720800 | ZNF genes & repeats | Pancreas | Pancrea |